LYRA (STOCKS)
LYRA THERAPEUTICS INC
$0.650000
+0.120000 (+22.64%)
Prev close: $0.530000
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Maria Palasis
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $43.94M
- Employees
- 30
- P/E (TTM)
- -3.62
- P/B (TTM)
- 1.56
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
0
Strong Buy
0
Buy
3
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-3.38 | $-5.36 | +1.9801 | +36.94% |
|
Jun 2025 (Q2)
|
$-5.51 | $-6.14 | +0.6304 | +10.27% |
|
Mar 2025 (Q1)
|
$-6.00 | $-6.97 | +0.9702 | +13.92% |
|
Dec 2024 (Q4)
|
$-8.00 | $-6.12 | -1.8800 | -30.72% |
Financial Statements
| Revenues | $398.00K |
| Benefits Costs and Expenses | $29.31M |
| Costs And Expenses | $29.31M |
| Nonoperating Income/Loss | $2.11M |
| Operating Expenses | $31.42M |
| Research and Development | $18.41M |
| Other Operating Expenses | $13.01M |
| Operating Income/Loss | -$31.02M |
| Income/Loss From Continuing Operations After Tax | -$28.92M |
| Income/Loss From Continuing Operations Before Tax | -$28.91M |
| Income Tax Expense/Benefit | $11.00K |
| Net Income/Loss | -$28.92M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$28.92M |
| Net Income/Loss Available To Common Stockholders, Basic | -$28.92M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$18.62 |
| Diluted Earnings Per Share | -$18.62 |
| Basic Average Shares | 1,553,473 |
| Diluted Average Shares | 1,553,473 |
| Assets | $36.11M |
| Current Assets | $16.27M |
| Noncurrent Assets | $19.84M |
| Fixed Assets | $1.05M |
| Other Non-current Assets | $18.79M |
| Liabilities | $46.83M |
| Current Liabilities | $9.52M |
| Accounts Payable | $663.00K |
| Wages | $257.00K |
| Other Current Liabilities | $8.60M |
| Noncurrent Liabilities | $37.30M |
| Equity | -$10.72M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$10.72M |
| Liabilities And Equity | $36.11M |
| Net Cash Flow From Operating Activities | -$28.86M |
| Net Cash Flow From Operating Activities, Continuing | -$28.86M |
| Net Cash Flow From Investing Activities | -$98.00K |
| Net Cash Flow From Investing Activities, Continuing | -$98.00K |
| Net Cash Flow From Financing Activities | $4.27M |
| Net Cash Flow From Financing Activities, Continuing | $4.27M |
| Net Cash Flow | -$24.68M |
| Net Cash Flow, Continuing | -$24.68M |
| Comprehensive Income/Loss | -$28.92M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$28.92M |
| Other Comprehensive Income/Loss | $0.00 |